Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Rubella Vaccine (Human Diploid Cell)，Live

Approval Number

国药准字S10980008

Company北京生物制品研究所有限责任公司

Registration Date

May 7, 2020

Drug Information

Generic Name

风疹减毒活疫苗(人二倍体细胞)

Dosage Form

冻干粉针剂

Strength

复溶后每瓶0.5ml。每1次人用剂量为0.5ml,含风疹活病毒应不低于3.2lgCCID50。

Drug Type

生物制品

Registration Date

May 7, 2020

Company Information

Applicant Company

Company Name北京生物制品研究所有限责任公司

Manufacturing Company

Company Name北京生物制品研究所有限责任公司

Company Address

北京市北京经济技术开发区博兴二路6、9号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy